HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-11-13FDA Approved: SUNLENCA — Supplemental Application (Gilead Sciences, Inc.)
This document reports an FDA supplemental application submission for Sunlenca (lenacapavir sodium) by Gilead Sciences, Inc., with the submis…
-
FDA label_change · 2024-11-13FDA Approved: SUNLENCA — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for Sunlenca (lenacapavir sodium) from Gilead Sciences, Inc., updating the drug’s labeling.
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: A Pragmatic Trial to Expand Youth-friendly HIV Self-testing [NA]
A pragmatic trial evaluating youth-friendly HIV self-testing has completed (NCT04710784), sponsored by Washington University School of Medic…
-
FDA approval · 2024-11-11FDA Approved: RETROVIR — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for RETROVIR (zidovudine) submitted by ViiV Healthcare Company.
-
FDA approval · 2024-11-07FDA Approved: DELSTRIGO — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for Delstrigo (doravirine/lamivudine/tenofovir disoproxil fumarate) submitted by Merck, resulting in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-11-07FDA Approved: PIFELTRO — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for PIFELTRO (doravirine) from Merck Sharp & Dohme LLC, updating the drug's labeling.
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Switch From Oral Therapy to Long-acting Injectable Cabotegravir + Rilpivirine
This clinical trial investigates switching from oral HIV therapy to a long-acting injectable regimen of cabotegravir plus rilpivirine; the s…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: Development and Pilot Testing of the Sense2Quit App [NA]
This update reports development and pilot testing of the Sense2Quit app, a digital intervention for smoking cessation, with results from a c…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Modelling the Interaction Between Rationally-designed Synthetic Model Viral Protein Immunogens [Phase 1]
Phase 1 study assessing interactions of rationally designed synthetic model viral protein immunogens in HIV infection; the study has complet…
-
CLINICAL_TRIALS research · 2024-11-05Clinical Trial Update: Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of 16055 NFL Delta Gly4 Env Protein Trimer and Trimer 4571 Combined With 3M-052-AF + Alum Adjuvant and Ad4-Env145NFL Viral Particles as Heterologous Prime-boost Regimens in Adult Participants Without HIV. [Phase 1]
Phase 1 trial evaluating safety, tolerability, and immunogenicity of HIV envelope protein trimers and related vaccine components. The regime…
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: HIV and Multi-Drug Resistant Tuberculosis: a Study on Clinical Outcomes
This clinical trial update reports on a study evaluating clinical outcomes in people co-infected with HIV and multidrug-resistant tuberculos…
-
CLINICAL_TRIALS research · 2024-11-01Clinical Trial Update: Improving HIV Testing, Linkage, and Retention in Care for Men Through U=U Messaging [NA]
A clinical trial is recruiting to evaluate improving HIV testing, linkage to care, and retention in care for men using U=U messaging.
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Clinical Trial to Evaluate the Safety and Immunogenicity of BG505 MD39.3, BG505 MD39.3 gp151, and BG505 MD39.3 gp151 CD4KO HIV Trimer mRNA Vaccines in Healthy, HIV-uninfected Adult Participants [Phase 1]
Phase 1 clinical trial evaluating safety and immunogenicity of three BG505 MD39.3 HIV trimer mRNA vaccines (with gp151 and CD4KO variants) i…
-
CLINICAL_TRIALS trial_result · 2024-10-29Clinical Trial Update: HOPE Social Media Intervention for HIV Testing and Studying Social Networks [NA]
HOPE is a social media intervention trial to promote HIV testing and study social networks. The trial has completed, and results have been p…
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: PREPARE (A5361s) Ancillary Study of REPRIEVE (A5332) [Phase 3]
Phase 3 ancillary study PREPARE (A5361s) of REPRIEVE (A5332) has completed and results were posted on 2024-10-28.
-
CLINICAL_TRIALS research · 2024-10-28Clinical Trial Update: Primary and Secondary Drug Resistance Mutations (DRMs) in HIV As a Risk Factor of Failure of ART, Including Two Drugs Based Regimens.
This clinical trial investigates how primary and secondary HIV drug-resistance mutations (DRMs) may predict failure of antiretroviral therap…
-
CLINICAL_TRIALS trial_result · 2024-10-26Clinical Trial Update: The Impact of Online Educator Mircoskill Training and Parent Microskill Training on Student Sexual-Health Related Outcomes [NA]
This completed clinical trial evaluated whether online educator microskill training and parent microskill training can influence student sex…
-
CLINICAL_TRIALS research · 2024-10-26Clinical Trial Update: Cohort IMEA 070 -Lenacapavir Compassional
Clinical trial update for Cohort IMEA 070 evaluating lenacapavir for HIV infection; the cohort is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: Antimalarial Pharmacology in Children and Pregnant Women in Uganda
This update reports on a completed clinical trial evaluating antimalarial pharmacology in children and pregnant women in Uganda. The study i…
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: Collision of Three Global Pandemics: the Effect of Tuberculosis and HIV on the Epidemiological, Clinical, Virological and Immunological Trajectory of COVID-19 in Botswana and Namibia
This completed clinical trial update studied how HIV seropositivity and tuberculosis affect the epidemiology, clinical trajectory, virology,…
-
CLINICAL_TRIALS research · 2024-10-24Clinical Trial Update: Imaging Immune Activation in HIV by PET-MR [Phase 2]
Phase 2 trial update evaluating imaging immune activation in HIV infections using PET-MR; currently recruiting.
-
FDA approval · 2024-10-23FDA Approved: NEVIRAPINE — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Nevirapine from Camber Pharmaceuticals (ANDA078584), approving changes to the generic produc…
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: Strategic Antiretroviral Therapy and HIV Testing for Youth in Rural Africa [NA]
The NCT03848728 trial evaluating strategic antiretroviral therapy and HIV testing for youth in rural Africa has completed. Results were post…
-
CLINICAL_TRIALS research · 2024-10-23Clinical Trial Update: Integrated Online-to-offline (O2O) Model of Care for HIV Prevention and Treatment Among Men Who Have Sex with Men [NA]
A clinical trial evaluating an integrated online-to-offline care model for HIV prevention and treatment among men who have sex with men, cur…
-
CLINICAL_TRIALS trial_result · 2024-10-22Clinical Trial Update: Gene Expression Outcomes in Interventions for Substance Using HIV+ Minority Men [NA]
This clinical trial update describes gene expression outcomes for interventions among substance-using HIV-positive minority men, and the stu…